Brutkiewicz et al., 2002 - Google Patents
Natural killer T (NKT) cells and their role in antitumor immunityBrutkiewicz et al., 2002
- Document ID
- 6466728922636699768
- Author
- Brutkiewicz R
- Sriram V
- Publication year
- Publication venue
- Critical reviews in oncology/hematology
External Links
Snippet
Natural killer T (NKT) cells have become a major focus for those who study the innate immune response to tumors and infectious diseases, as well as autoimmunity. These novel T lymphocytes produce both Th1 and Th2 cytokines, recognize phospholipid and glycolipid …
- 210000000581 Natural Killer T-Cells 0 title abstract description 213
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brutkiewicz et al. | Natural killer T (NKT) cells and their role in antitumor immunity | |
Gumperz et al. | CD1-specific T cells in microbial immunity | |
Karl et al. | The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy | |
Murphy et al. | Innate immunity in transplant tolerance and rejection | |
Brigl et al. | How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens | |
Karumuthil-Melethil et al. | Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes | |
Manicassamy et al. | Dendritic cell control of tolerogenic responses | |
Terabe et al. | The role of NKT cells in tumor immunity | |
Tyler et al. | Human Vγ9/Vδ2 T cells: innate adaptors of the immune system | |
Jungraithmayr et al. | Cytokine complex–expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells | |
Hobbs et al. | Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus | |
CA2441213C (en) | Cd4+cd25+ regulatory t cells from human blood | |
Nieda et al. | Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner | |
Bedard et al. | Harnessing the power of invariant natural killer T cells in cancer immunotherapy | |
Fleuridor et al. | CD1d‐restricted natural killer T cells are potent targets for human immunodeficiency virus infection | |
Pilones et al. | Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes | |
Bihl et al. | Mechanisms of NK cell activation: CD4+ T cells enter the scene | |
Ferlazzo et al. | Dendritic cell interactions with NK cells from different tissues | |
Hung et al. | Tailored design of NKT-stimulatory glycolipids for polarization of immune responses | |
Bialecki et al. | Role of marginal zone B lymphocytes in invariant NKT cell activation | |
Schuetz et al. | Regulatory B cell-dependent islet transplant tolerance is also natural killer cell dependent | |
Seino et al. | Functional roles of NKT cell in the immune system | |
Singh et al. | Differential dendritic cell‐mediated activation and functions of invariant NKT‐cell subsets in oral cancer | |
Tan et al. | Type I natural killer T cells: naturally born for fighting | |
Oh et al. | Role of type II NKT cells in the suppression of graft-versus-host disease |